Streetbeat News

Products Services

DSNKY

Australian biotech startup Psylo has entered into a sponsored research agreement with Japanese pharmaceutical company Daiichi Sankyo (OTC:DSNKY) to advance the development of antidepressant psychiatric medicines. Psylo will leverage its expertise in neuropsychiatric therapies and Daiichi Sankyo's experience in drug discovery and clinical development to research potential treatments for chronic mental illnesses.

Portfolio Pulse from Lara Goldstein

June 27, 2023 | 9:00 pm

PLTR

Shares of Palantir Technologies Inc (NYSE:PLTR) have more than doubled since the start of the year, largely driven by the AI boom and the company's positioning in the space. The rally in Palantir shares accelerated last month after the company reported better-than-expected quarterly results and guided for continued profitability in 2023. CEO Alex Karp highlighted extraordinary demand for the company's AI products in recent months, similar to Nvidia.

Portfolio Pulse from Ryan Gustafson

June 27, 2023 | 8:59 pm

IGT

IGT has secured a contract with Dreamscape Companies to provide its IGT ADVANTAGE casino management system to the Rio Hotel & Casino starting Q4 of this year. The terms of the agreement were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 8:34 pm

GEOS

Geospace Technologies Corporation (NASDAQ:GEOS) has signed a major rental contract for its Mariner product with an international marine geophysical services provider. The contract, which includes the rental of shallow water seabed wireless seismic data acquisition nodes, is expected to be worth $20 million. Delivery of the Mariners will occur in the first quarter of fiscal year 2024. The Mariner product was launched less than a year ago and has seen rapid market adoption.

Portfolio Pulse from Happy Mohamed

June 27, 2023 | 8:32 pm

AMZN

GOOG

PTON

Peloton is beta testing a new feature that allows users to stream videos from Amazon Prime Video and YouTube on their Peloton devices. The feature is being tested on the original Bike, Bike+, Tread, Tread+, and Row. The workout will be recorded to the user's Peloton profile as an 'Entertainment' workout. The feature has not fully launched and is currently only beta testing with a randomized group of members.

Portfolio Pulse from Happy Mohamed

June 27, 2023 | 8:13 pm

TOVX

Theriva Biologics has been granted Orphan Drug Designation by the US FDA for VCN-01, a treatment for pancreatic cancer. The designation will provide various benefits including tax credits, market exclusivity, and FDA assistance for clinical studies.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 8:10 pm

RZLT

Rezolute, Inc. (NASDAQ:RZLT) plans to initiate a pivotal Phase 3 clinical study of RZ358, its product candidate for congenital hyperinsulinism, in Europe and other geographies outside the US in Q4 2023, with topline results expected in 1H 2025. The study follows the successful Phase 2b RIZE study which demonstrated that RZ358 was safe, well-tolerated, and effective. However, due to FDA restrictions, it is infeasible to include the US in the study at this time.

Portfolio Pulse from Happy Mohamed

June 27, 2023 | 8:07 pm

PRTA

Prothena Corporation has announced the publication of its Phase 3 VITAL clinical trial results in the Blood Journal. The results of this trial could have significant implications for the company's future drug development and market position.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 8:07 pm

AYX

SNOW

Alteryx, Inc. (NYSE:AYX) has announced its Snowflake Partner Connect integration and additional cloud product capabilities at Snowflake's annual user conference, Snowflake Summit 2023. The integration simplifies the data stack and enables users to drive analytic insights more efficiently with direct access to the Alteryx Analytics Cloud Platform through Snowflake. The integration also offers a free trial of the Alteryx Analytics Cloud Platform for new users, automatically configuring a Snowflake connection to Alteryx.

Portfolio Pulse from Happy Mohamed

June 27, 2023 | 8:06 pm

LFLY

Leafly has been granted U.S. Patent #11687994 for 'Systems For Selection Of Cannabis-Related Products And Visualization Of Chemical Data'. The patent involves the use of artificial intelligence in the decision engine.

Portfolio Pulse from Happy Mohamed

June 27, 2023 | 8:00 pm